A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00069095 Information provided by Hoffmann-La Roche

First Received: September 15, 2003 Last Updated: October 15, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	No date given